🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › New Jersey › Clifton

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Clifton, NJ keessatti

Qorannoo 12 Leukemia Myeloidii Hamaa f Clifton fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Namoota walitti qabaa jiraSadarkaa 2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06824168

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Hackensack University Medical Center, HMH, Hackensack · Miili 7 fagaatti
29 Days – 21 Years · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • John Theurer Cancer Center / Hackensack University, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

Phase IB/II of CPX-351 for Relapse Prevention in AML

Namoota walitti qabaa jiraSadarkaa 1/2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT04990102

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Clifton keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.